First Analysis Starts Pacific Biosciences of California (PACB) at Overweight
Tweet
Share
E-mailGet Alerts PACB Hot Sheet
Price: $1.44 +9.92%
Rating Summary:
9 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 54
Rating Summary:
9 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 54
Join SI Premium – FREE
First Analysis initiated coverage on Pacific Biosciences of California (NASDAQ: PACB) with an Overweight rating and a price target of $11.00.
For an analyst ratings summary and ratings history on Pacific Biosciences of California click here. For more ratings news on Pacific Biosciences of California click here.
Shares of Pacific Biosciences of California closed at $8.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rosenblatt Starts CoreWeave (CRWV) at Buy
- Freedom Capital Starts Sezzle Inc (SEZL) at Hold
- Loop Capital Starts Shift4 Payments (FOUR) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
First AnalysisSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
